West Virginia University, Morgantown, West Virginia (S.U.K., M.U.K., S.V.).
Cleveland Clinic, Cleveland, Ohio (H.R.).
Ann Intern Med. 2019 Aug 6;171(3):190-198. doi: 10.7326/M19-0341. Epub 2019 Jul 9.
The role of nutritional supplements and dietary interventions in preventing mortality and cardiovascular disease (CVD) outcomes is unclear.
To examine evidence about the effects of nutritional supplements and dietary interventions on mortality and cardiovascular outcomes in adults.
PubMed, CINAHL, and the Cochrane Library from inception until March 2019; ClinicalTrials.gov (10 March 2019); journal Web sites; and reference lists.
English-language, randomized controlled trials (RCTs) and meta-analyses of RCTs that assessed the effects of nutritional supplements or dietary interventions on all-cause mortality or cardiovascular outcomes, such as death, myocardial infarction, stroke, and coronary heart disease.
Two independent investigators abstracted data, assessed the quality of evidence, and rated the certainty of evidence.
Nine systematic reviews and 4 new RCTs were selected that encompassed a total of 277 trials, 24 interventions, and 992 129 participants. A total of 105 meta-analyses were generated. There was moderate-certainty evidence that reduced salt intake decreased the risk for all-cause mortality in normotensive participants (risk ratio [RR], 0.90 [95% CI, 0.85 to 0.95]) and cardiovascular mortality in hypertensive participants (RR, 0.67 [CI, 0.46 to 0.99]). Low-certainty evidence showed that omega-3 long-chain polyunsaturated fatty acid (LC-PUFA) was associated with reduced risk for myocardial infarction (RR, 0.92 [CI, 0.85 to 0.99]) and coronary heart disease (RR, 0.93 [CI, 0.89 to 0.98]). Folic acid was associated with lower risk for stroke (RR, 0.80 [CI, 0.67 to 0.96]; low certainty), whereas calcium plus vitamin D increased the risk for stroke (RR, 1.17 [CI, 1.05 to 1.30]; moderate certainty). Other nutritional supplements, such as vitamin B6, vitamin A, multivitamins, antioxidants, and iron and dietary interventions, such as reduced fat intake, had no significant effect on mortality or cardiovascular disease outcomes (very low- to moderate-certainty evidence).
Suboptimal quality and certainty of evidence.
Reduced salt intake, omega-3 LC-PUFA use, and folate supplementation could reduce risk for some cardiovascular outcomes in adults. Combined calcium plus vitamin D might increase risk for stroke.
None.
营养补充剂和饮食干预在预防死亡率和心血管疾病(CVD)结局方面的作用尚不清楚。
研究营养补充剂和饮食干预对成年人死亡率和心血管结局的影响的证据。
PubMed、CINAHL 和 Cochrane 图书馆从成立到 2019 年 3 月;ClinicalTrials.gov(2019 年 3 月 10 日);期刊网站;和参考文献列表。
评估营养补充剂或饮食干预对全因死亡率或心血管结局(如死亡、心肌梗死、卒中和冠心病)影响的英文随机对照试验(RCT)和 RCT 荟萃分析。
两名独立的调查员提取数据、评估证据质量,并对证据确定性进行评级。
共选择了 9 项系统评价和 4 项新的 RCT,共涵盖了 277 项试验、24 项干预措施和 992129 名参与者。共生成了 105 项荟萃分析。有中等确定性证据表明,减少盐摄入量可降低正常血压参与者的全因死亡率(风险比[RR],0.90 [95%CI,0.85 至 0.95])和高血压参与者的心血管死亡率(RR,0.67 [CI,0.46 至 0.99])。低确定性证据表明,ω-3 长链多不饱和脂肪酸(LC-PUFA)与降低心肌梗死(RR,0.92 [CI,0.85 至 0.99])和冠心病(RR,0.93 [CI,0.89 至 0.98])的风险相关。叶酸与降低卒中风险相关(RR,0.80 [CI,0.67 至 0.96];低确定性),而钙加维生素 D 增加卒中风险(RR,1.17 [CI,1.05 至 1.30];中等确定性)。其他营养补充剂,如维生素 B6、维生素 A、多种维生素、抗氧化剂和铁,以及饮食干预,如减少脂肪摄入,对死亡率或心血管疾病结局没有显著影响(非常低至中等确定性证据)。
证据质量和确定性不佳。
减少盐摄入量、ω-3 LC-PUFA 的使用和叶酸补充可能会降低成年人某些心血管结局的风险。联合使用钙加维生素 D 可能会增加卒中风险。
无。